in each batch was above 95% and the enzymatic activity still remained quite high after five batches of biotransformation.
CONCLUSION: The results showed that performing the conversion by this method shortened the reaction time and increased the productivity, thus demonstrating the great potential of the method for the dehydrogenation of 11 alpha-hydroxy-16 alpha,17-epoxyprogesterone. (C) 2008 Society of Chemical Industry”
“Contents To achieve optimal reproductive performance in pig herds, sows need to become pregnant as soon as possible after weaning. The aim of this study was to investigate herd and management factors associated with reproductive GF120918 supplier performance of sows after weaning. A questionnaire pertaining to sow management at weaning and herd reproductive data were collected from 76 randomly selected commercial pig herds in Belgium. Associations between the herd factors and two reproductive parameters after weaning (weaning-to-oestrous interval: WEI and percentage of repeat breeders: RB) were analysed using general linear mixed models. A separated feeding strategy of breeding gilts from 60kg onwards was significantly
associated with a shorter WEI (5.54 vs 7.28days; p=0.040). Factors significantly associated with a lower percentage of RB were housing the newly weaned sows separated from the gestating sows (7% vs 12%; p=0.003), using semen<4days after collection LCL161 mouse (79 vs 14%; p=0.014) and stimulating oestrus twice a day (8 vs 11%; p=0.025). In conclusion, some management practices, such as feeding strategy of breeding gilts, housing conditions of sows, method of oestrous stimulation and storage duration of semen, have an influence on the outcome of reproductive parameters such as weaning-to-oestrous interval R788 inhibitor and percentage of repeat breeders. These practices can be implemented rather easily by pig producers and may consequently lead to improvements of reproductive performance of sows after weaning.”
“OBJECTIVE: The purpose of this study was to compare the efficacy and tolerability of combination therapy of ezetimibe and atorvastatin in patients with high LDL cholesterol that
had not reached the lipid management target value with 10 mg atorvastatin monotherapy, against increasing the dose to 20 mg atorvastatin or switching to 2.5 mg rosuvastatin.
DESIGN, SETTING, AND PARTICIPANTS: This was an open-label, randomized, multicenter, 3-parallel-group comparison trial at 23 community hospitals and clinics in Japan (enrollment period March 2009 to May 2010) in 125 patients with high LDL cholesterol.
INTERVENTIONS: A total of 125 Japanese patients with high LDL cholesterol level were randomized to 1 of the following 3 treatment groups: the ezetimibe (10 mg/d) and atorvastatin (10 mg/d) group, the atorvastatin (20 mg/d) group, or the rosuvastatin (2.5 mg/d) group for 12 weeks after treatment with 10 mg atorvastatin alone for 4 weeks.